Tofacitinib Clinical Trials

A listing of Tofacitinib medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Tofacitinib for Treatment of Moderate COVID-19

The purpose of this randomized, double blinded, placebo controlled study is to assess the efficacy and safety of tofacitinib in hospitalized adult (18-65 years old) patients with SARS-CoV-2 and pneumonia who require supplemental oxygen and have serologic markers of inflammation but do not need mechanical ventilation.

hs-crp
coronavirus infection
acute respiratory syndrome (sars)
ct scan
chest x-ray
  • 0 views
  • 05 Aug, 2020
Tofacitinib for Immune Skin Conditions in Down Syndrome

The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug known to block IFN signaling, in adults with DS and an autoimmune and/or autoinflammatory skin condition.

disseminated herpes simplex
down syndrome
herpes zoster
unbalanced translocation
dermatosis
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms

The study is a prospective, randomized, controlled investigation designed for comparison of two groups for the reduction of respiratory distress in a CoViD-19 population, using gammaCore Sapphire (nVNS) plus standard of care (active) vs. standard of care alone (SoC), the control group. The gammaCore (nVNS) treatments will be used acutely …

vagal nerve stimulation
cough
vagus nerve stimulation
respiratory distress
dyspnea
  • 0 views
  • 16 Feb, 2024
  • 1 location
Comparative Effectiveness of Targeted Therapy in RA Patients

The objective of a multicenter prospective observational study is to compare effectiveness and safety of biologic disease-modifying antirheumatic drugs and small molecular inhibitors in patients with moderately to severely active rheumatoid arthritis patients who have had an inadequate response or intolerace to methotrexate.

abatacept
methotrexate
disease modifying antirheumatic drugs
DMARD
antirheumatics
  • 0 views
  • 16 Feb, 2024
  • 1 location